biosig.com (STEX) - Forward P/S Multiple

Streamex Corp. - graphic logo of issuer STEX

The expected price-to-sales ratio for Streamex Corp (STEX) reflects the current trend, with the present value standing at 235.80. Revenue stability is driven by the deep integration of cardiology software within medical centers. Despite elastic demand, the PURE EP platform isolates critical ECG signals. Growth is currently stimulated by asset optimization following restructuring, while debt risks are already priced in.

Streamex Corporation - STEX Market Cap to Future Revenue Ratio (period 09/13/2025 - 11/13/2026)

Analytical breakdowns for biosig.com (STEX)

- market price and analyst price targets:
Price Chart Streamex|STEX - Fair Value Consensus
- market capitalization indicators:
Market Capitalization STEX|STEX - Real Price to Acquire Entire Company
- issuer book value statistics:
Book Value per Share Streamex Corp|STEX - Total Stockholders' Equity|Market Value to Book Value Ratio biosig.com|STEX - Company Total Asset Base
- debt level and financial liquidity data:
Total Debt to Equity Ratio Streamex Corp|STEX - Long-Term Loans to Capital Ratio|Short-Term Debt to Equity Streamex|STEX - Aggregate Debt Obligations|Debts to Book Capitalization STEX|STEX - Long-Term Debt|Company Short-Term Debts Streamex Corp|Quick Liquidity biosig.com
- financial results and valuation multiples details:
STEX - Net Income|Projected Future Earnings Streamex Corp|STEX - Market Cap to Earnings|Projected Price to Earnings Streamex|STEX - Growth-Adjusted P/E Ratio|Enterprise Value to EBITDA Ratio STEX|STEX - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) Streamex Corp|STEX - Net earnings per share for the last 12 months|Year-over-year earnings per share growth for the last twelve months biosig.com|STEX - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Streamex Corp
- revenue and sales details:
STEX - Company Sales Revenue|Company Projected Revenue Streamex|STEX - Price-to-Sales Ratio|Price-to-Projected Revenue Ratio STEX
Summary company analysis:Streamex Corp. STEX
Manufactured products of Streamex

The success of Streamex Corp (STEX) depends on the adoption rate of cardiology systems in clinics, which directly impacts future sales dynamics. The ratio of current market capitalization to projected revenue allows for an assessment of the asset's fair market value, while the future P/S multiple signals to the investor the risk of overpaying for the company amid stagnant revenues or rising operating expenses.

Competitor analysis

Price-to-Projected Revenue Ratio Texas Pacific Land Corporation TPL|Forward Price to Sales RPRX|Viper Energy Corp - Forward P/S Multiple|Black Stone Minerals Inc. (BSM) - Forward Price-to-Revenue Multiple|NOG: Forward P/S Multiple|Market Cap to Future Revenue Ratio dmlp.net (DMLP)|Price-to-Projected Revenue Ratio Sabine Royalty Trust REIT|Vitesse Energy Inc (VTS) - Market Cap to Expected Sales Ratio|Forward Price-to-Revenue Multiple PBT (PBT Trust)|Price to Expected Revenue Ratio TXO|Price-to-Projected Revenue Ratio Granite Ridge Resources GRNT|Forward Price to Sales XOMA|San Juan Basin Royalty - Forward P/S Multiple|Market Cap to Future Revenue Ratio Scully Royalty Ltd.|MVO: Forward P/S Multiple|Permianville Royalty Trust Inc (PVL) - Forward P/S Multiple|Price-to-Projected Revenue Ratio VOC Energy Trust|Forward Price-to-Revenue Multiple crt-crosstimbers.com (CRT)|Forward P/S Multiple PRT|RMCO - Market Cap to Future Revenue Ratio|CKX Lands - Forward Price-to-Revenue Multiple|MTR: Market Cap to Projected Revenue|BPT: Forward Price-to-Revenue Multiple|Forward Price to Sales PHX (phxmin.com)|STR: Forward P/S Multiple